{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:54:56Z","timestamp":1792086896950,"version":"4.4.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,7,16]],"date-time":"2009-07-16T00:00:00Z","timestamp":1247702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1478-811x-7-17","type":"journal-article","created":{"date-parts":[[2009,7,16]],"date-time":"2009-07-16T14:16:24Z","timestamp":1247753784000},"source":"Crossref","is-referenced-by-count":58,"title":["HSP90 is essential for Jak-STAT signaling in classical Hodgkin lymphoma cells"],"prefix":"10.1186","volume":"7","author":[{"given":"Nils","family":"Schoof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederike","family":"von Bonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"Tr\u00fcmper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Kube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,16]]},"reference":[{"key":"65_CR1","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1182\/blood.V99.2.618","volume":"99","author":"BF Skinnider","year":"2002","unstructured":"Skinnider BF, Elia AJ, Gascoyne RD, Patterson B, Tr\u00fcmper L, Kapp U, Mak TW: Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood. 2002, 99: 618-626. 10.1182\/blood.V99.2.618.","journal-title":"Blood"},{"key":"65_CR2","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/sj.leu.2403750","volume":"19","author":"U Holtick","year":"2005","unstructured":"Holtick U, Vockerodt M, Pinkert D, Schoof N, St\u00fcrzenhofecker B, Kussebi N, Lauber K, Wesselborg S, Loffler D, Horn F, et al.: STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis. Leukemia. 2005, 19: 936-944. 10.1038\/sj.leu.2403750.","journal-title":"Leukemia"},{"key":"65_CR3","volume-title":"Cell Signal","author":"O Cochet","year":"2005","unstructured":"Cochet O, Frelin C, Peyron JF, Imbert V: Constitutive activation of STAT proteins in the HDLM-2 and L540 Hodgkin lymphoma-derived cell lines supports cell survival. Cell Signal. 2005"},{"key":"65_CR4","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1158\/1078-0432.CCR-05-1194","volume":"12","author":"GV Georgakis","year":"2006","unstructured":"Georgakis GV, Li Y, Rassidakis GZ, Martinez-Valdez H, Medeiros LJ, Younes A: Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death. Clin Cancer Res. 2006, 12: 584-590. 10.1158\/1078-0432.CCR-05-1194.","journal-title":"Clin Cancer Res"},{"key":"65_CR5","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/sj.leu.2404565","volume":"21","author":"M Janz","year":"2007","unstructured":"Janz M, Stuhmer T, Vassilev LT, Bargou RC: Pharmacologic activation of p53-dependent and p53-independent apoptotic pathways in Hodgkin\/Reed-Sternberg cells. Leukemia. 2007, 21: 772-779.","journal-title":"Leukemia"},{"key":"65_CR6","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1074\/jbc.M509901200","volume":"281","author":"L Shang","year":"2006","unstructured":"Shang L, Tomasi TB: The heat shock protein 90-CDC37 chaperone complex is required for signaling by types I and II interferons. J Biol Chem. 2006, 281: 1876-1884. 10.1074\/jbc.M509901200.","journal-title":"J Biol Chem"},{"key":"65_CR7","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/ijc.21539","volume":"118","author":"D Baus","year":"2006","unstructured":"Baus D, Pfitzner E: Specific function of STAT3, SOCS1, and SOCS3 in the regulation of proliferation and survival of classical Hodgkin lymphoma cells. Int J Cancer. 2006, 118: 1404-1413. 10.1002\/ijc.21539.","journal-title":"Int J Cancer"},{"key":"65_CR8","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1182\/blood.V98.3.762","volume":"98","author":"D Kube","year":"2001","unstructured":"Kube D, Holtick U, Vockerodt M, Ahmadi T, Haier B, Behrmann I, Heinrich PC, Diehl V, Tesch H: STAT3 is constitutively activated in Hodgkin cell lines. Blood. 2001, 98: 762-770. 10.1182\/blood.V98.3.762.","journal-title":"Blood"},{"key":"65_CR9","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1080\/10428190701607576","volume":"48","author":"J Bareng","year":"2007","unstructured":"Bareng J, Jilani I, Gorre M, Kantarjian H, Giles F, Hannah A, Albitar M: A potential role for HSP90 inhibitors in the treatment of JAK2 mutant-positive diseases as demonstrated using quantitative flow cytometry. Leuk Lymphoma. 2007, 48: 2189-2195. 10.1080\/10428190701607576.","journal-title":"Leuk Lymphoma"},{"key":"65_CR10","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1182\/blood-2005-05-1889","volume":"106","author":"R Kralovics","year":"2005","unstructured":"Kralovics R, Teo SS, Buser AS, Brutsche M, Tiedt R, Tichelli A, Passamonti F, Pietra D, Cazzola M, Skoda RC: Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2. Blood. 2005, 106: 3374-3376. 10.1182\/blood-2005-05-1889.","journal-title":"Blood"},{"key":"65_CR11","doi-asserted-by":"publisher","first-page":"41893","DOI":"10.1074\/jbc.C500358200","volume":"280","author":"J Staerk","year":"2005","unstructured":"Staerk J, Kallin A, Demoulin JB, Vainchenker W, Constantinescu SN: JAK1 and Tyk2 activation by the homologous polycythemia vera JAK2 V617F mutation: cross-talk with IGF1 receptor. J Biol Chem. 2005, 280: 41893-41899. 10.1074\/jbc.C500358200.","journal-title":"J Biol Chem"},{"key":"65_CR12","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1038\/sj.leu.2404325","volume":"20","author":"S Schnittger","year":"2006","unstructured":"Schnittger S, Bacher U, Kern W, Schroder M, Haferlach T, Schoch C: Report on two novel nucleotide exchanges in the JAK2 pseudokinase domain: D620E and E627E. Leukemia. 2006, 20: 2195-2197. 10.1038\/sj.leu.2404325.","journal-title":"Leukemia"},{"key":"65_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/sj.leu.2404036","volume":"20","author":"I Melzner","year":"2006","unstructured":"Melzner I, Weniger MA, Menz CK, Moller P: Absence of the JAK2 V617F activating mutation in classical Hodgkin lymphoma and primary mediastinal B-cell lymphoma. Leukemia. 2006, 20: 157-158. 10.1038\/sj.leu.2404036.","journal-title":"Leukemia"},{"key":"65_CR14","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1182\/blood-2008-01-134783","volume":"112","author":"B Lamprecht","year":"2008","unstructured":"Lamprecht B, Kreher S, Anagnostopoulos I, Johrens K, Monteleone G, Jundt F, Stein H, Janz M, Dorken B, Mathas S: Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3alpha. Blood. 2008, 112: 3339-3347. 10.1182\/blood-2008-01-134783.","journal-title":"Blood"},{"key":"65_CR15","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1084\/jem.20020062","volume":"196","author":"M Hinz","year":"2002","unstructured":"Hinz M, Lemke P, Anagnostopoulos I, Hacker C, Krappmann D, Mathas S, D\u00f6rken B, Zenke M, Stein H, Scheidereit C: Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity. J Exp Med. 2002, 196: 605-617. 10.1084\/jem.20020062.","journal-title":"J Exp Med"},{"key":"65_CR16","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/sj.onc.1210716","volume":"27","author":"M Ammirante","year":"2008","unstructured":"Ammirante M, Rosati A, Gentilella A, Festa M, Petrella A, Marzullo L, Pascale M, Belisario MA, Leone A, Turco MC: The activity of hsp90 alpha promoter is regulated by NF-kappa B transcription factors. Oncogene. 2008, 27: 1175-1178. 10.1038\/sj.onc.1210716.","journal-title":"Oncogene"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1478-811X-7-17.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1478-811X-7-17\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1478-811X-7-17.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T18:49:30Z","timestamp":1548182970000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/1478-811X-7-17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,16]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["65"],"URL":"https:\/\/doi.org\/10.1186\/1478-811x-7-17","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,16]]},"article-number":"17"}}